Stock CYTO ALTAMIRA THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Altamira Therapeutics Nasdaq

Equities

CYTO

BMG0360L2099

Market Closed - Nasdaq
Other stock markets
 03:59:50 2024-07-12 pm EDT 		5-day change 1st Jan Change
1.31 USD -0.76% Intraday chart for Altamira Therapeutics +2.34% -62.36%
Jun. 20 Altamira Therapeutics Ltd. Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management CI
May. 16 Altamira Therapeutics Ltd. Elects Dominik Lysek as Member of Board of Directors CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 126B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 119B
ARGENX SE Stock argenx SE
 27.95B -
BIONTECH SE Stock BioNTech SE
 20.5B -
GENMAB A/S Stock Genmab A/S
 17.12B
  1. Stock Market
  2. Equities
  3. CYTO Stock
  4. CYTO Stock
  5. Charts Altamira Therapeutics
  6. Sector Chart